Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis
The intestinal microbiome has been identified as a key modifier for a variety of health conditions. Fecal Microbiota Transplantation (FMT) has emerged as a fast, safe, and effective means by which to modify the intestinal microbiome and potentially treat a variety of health conditions. Despite exten...
Main Authors: | Jessica Emily Green, Jessica A. Davis, Michael Berk, Christopher Hair, Amy Loughman, David Castle, Eugene Athan, Andrew A. Nierenberg, John F. Cryan, Felice Jacka, Wolfgang Marx |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-11-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19490976.2020.1854640 |
Similar Items
-
Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond
by: Thomas J. Borody, et al.
Published: (2015-07-01) -
Reevaluating fecal microbiota transplantation for recurrent clostridium difficile infection
by: Hamilton, Mariah
Published: (2018) -
Tigecycline for severe Clostridium difficile infection
by: Ashley Thomas, et al.
Published: (2014-09-01) -
Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation
by: Kai Markus Schneider, et al.
Published: (2018-02-01) -
Guidelines for Clostridium difficile infection in adults
by: Michał Kukla, et al.
Published: (2020-03-01)